Financings in Brief: Ventana Medical Systems
This article was originally published in The Gray Sheet
Executive Summary
Ventana Medical Systems: Instrument and reagent manufacturer files registration statement with SEC for a secondary offering of 2.9 mil. shares, including 1.9 mil. to be sold by the company and 1 mil. by selling shareholders. Net proceeds from the offering will go toward "general corporate purposes, which may include expansion of sales and marketing activities, research and development, clinical trials, capital expenditures, repayment of indebtedness and working capital." Dillon, Read & Co. will serve as lead managers for the offering; Bear, Stearns and Cowen & Company are co-managers. Underwriters have an over-allotment option covering 427,500 additional shares, which would be sold by shareholders...
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.